Sort
64,565 grants matching “drug discovery”
Discovery and optimization of ApoE4 correctors for the treatment of Alzheimer's Disease
$730,480Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · AG
Structural variants of Abeta oligomer displacing small molecules
$730,417Susan M Catalano · Cognition Therapeutics, Inc. · R44 · FY2019 · AG
Understanding lung cancer genomics in patients of African ancestry
$730,400Jian Zhang · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Understanding lung cancer genomics in patients of African ancestry
$730,398Jian Zhang · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Evolution and inhibition of carbapenemase in beta-lactam resistance
$730,394Yu Chen · University Of South Florida · R01 · FY2023 · AI
Novel lead compound advancement for mitigating halogen-induced mortality and morbidity.
$730,351Shama Ahmad · University Of Alabama At Birmingham · U01 · FY2023 · ES
Discovering Small Molecule Biased Agonists for the Neuropeptide S Receptor
$730,330Scott P Runyon · Research Triangle Institute · R01 · FY2022 · MH
Whole genome profiling to detect schizophrenia methylation markers
$730,287Edwin Van Den Oord · Virginia Commonwealth University · RC2 · FY2010 · MH
Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline
$730,245Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2023 · AI
Exploiting Vulnerability on Influenza Virus
$730,213Ian A Wilson · Scripps Research Institute, The · R56 · FY2017 · AI
An Imaging Repository for the Cerebrovascular Disease Knowledge Portal (iCDKP)
$730,205Jonathan Rosand · Broad Institute, Inc. · U24 · FY2025 · NS
mTOR as a Central Regulator of iMCD Pathogenesis and Novel Therapeutic Target
$730,148David C Fajgenbaum · University Of Pennsylvania · R01 · FY2020 · HL
The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
$730,135Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Genetics and Molecular Mechanisms of Prostate Cancer
$730,131William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Development of Anticancer Agents
$730,131William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
$730,106Jun Wang · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
Non-Melanoma Skin Cancer in New Hampshire
$730,106Margaret Rita Karagas · Dartmouth College · R01 · FY2014 · CA
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors
$730,032Andrew L Kung · Sloan-Kettering Inst Can Research · U01 · FY2023 · CA
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors
$730,032Andrew L Kung · Sloan-Kettering Inst Can Research · U01 · FY2024 · CA
ETIOLOGY OF SUBSTANCE USE IN AUSTRALIA /USA
$729,960University Of Washington · R01 · FY2000 · DA
Genomic Background of Blood Pressure Response to Thiazide Diuretic in African Americans
$729,853Marguerite R Irvin · University Of Alabama At Birmingham · R01 · FY2019 · HL
BD2K product for enhancing phenotypic screens
$729,842Jennifer Fuller · Genecentrix, Inc. · R44 · FY2020 · DA
Combine computational prediction, network analysis and genetic screening in C elegans to uncover neurodegenerative causes in Alzheimer's Disease
$729,794Rong Xu · Case Western Reserve University · R01 · FY2020 · AG
Structural Basis of Signal Instigation Through Metabotropic Glutamate Receptors
$729,780Georgios Skiniotis · Stanford University · R01 · FY2019 · NS
Origin of Cortical Species-specific Distinctions.
$729,725Pasko Rakic · Yale University · R01 · FY2014 · DA